NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements. Scott…
Pfizer, Idorsia and AbbVie drug brands lead the way in pharma digital marketing — study
What do popular Stanley insulated cups have in common with two pharma migraine brands? They’re all transformational digital brands, according to new research out this